Basic Research

Funding of an individual investigator can be found in the member
links to their home pages. The following programmatic grant and
activities relate specifically to the activities initiated through the

1R01DA022370: Mechanisms of Carisoprodol Abuse
2 P01 AG022550: Mechanisms of Cognitive Decline During Aging
1 R01 AG027353: Brain Aging and Antioxidant Supplementation
N01DA-7-8872: Rodent Drug Discrimination and Locomotor Activity
Testing for NIDA
BK-1736: Structure Determination of a Chloride Ion Channel to
Atomic Resolution
R01 AA01582: Effects of Age on Ethanol Withdrawal Toxicity: Mechanisms
and Therapy
1R21AA018747: Intermittent Hypoxia Protects Brain from Ethanol
Withdrawal: Mechanisms and Therapy
1R01DA029840: PET Radiotracers for Imaging the Dopamine D3 Receptor
1 R21 MH081281: Dopamine D2 Selective Imaging Agents
1 R01DA023957: D3 Receptor Compounds for the Treatment of
Psychostimulant Abuse
1R21AG031421: Novel Molecular Probes for Membrane Progesterone
1P01AG027956: Novel Mechanistic Targets of Steroid Hormones in the
1 P20 MD001633: Role of Ethnicity in the Features of Hot Flashes in
Menopausal Women
2 T32 AG020494: Training in the Neurobiology of Aging
W81XWH-10-2-0003: Vision Integrating Strategies in Opthalmology and
Neurochemistry (VISION)
IIRG-07-59767: Progestin-regulated Neurotrophin Synthesis and Release
in Neuroprotection
10BGIA4180116: The Role of Androgens and Oxidative Stress in Dopamine
2R01NS00039951: Gonadal Steroid Receptors and the Hypothalamo
Pituitary-Adrenal Axis
1 R01 MH082900: GR-mediated Epigenetic Regulation of the CRH Gene
Nestle Sponsored: Assessment of Nestle Diet on Long-Term Outcome after
Ischemic Stroke in Female (Phase 4A) and Male Rats
(Phase 4B)
1 R01 NS054687: Interaction of Estrogen and Tissue Plasminogen Activator
Nestle Sponsored: Assessment of the Effects of Nestle Diets in an
Alzheimer’s Disease Model in Female (Phase 5A) and Male
Mouse (Phase 5B)
4R33NS052850: Computational Optical Tomography for Anti-stroke
1R01NS054651: Vascular Cognitive Impairment Induced by Ischemic
Stroke: Mechanism and Therapy
1 R01 EY016242: Glucocorticoids, Ocular Hypertension and Glaucoma"

This page was last modified on November 30, -0001